Growth inhibition by pennogenyl saponins from Rhizoma paridis on hepatoma xenografts in nude mice

Steroids

Volumn 83, Issue , 2014, Pages 39-44

  Chen, Ya Shu ^a   He, Yao ^a   Chen, Chu ^a,b   Zeng, Yi ^a   Xue, Dan ^b   Wen, Fei Yan ^b   Wang, Ling ^c   Zhang, Hao ^a   Du, Jun Rong ^a  

^a SICHUAN UNIVERSITY   (China)

^b Sichuan Academy of Traditional Chinese Medicine Sciences   (China)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Anticancer activity; Hepatocellular carcinoma; Nude mice; Pennogenyl saponins; Rhizoma paridis axialis

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE; PENNOGENIN 3 O ALPHA LEVO RHAMNOPYRANOSYL(1-4)ALPHA LEVO RHAMNOPYRANOSYL(1-4)[O BETA DEXTRO GLUCOPYRANOSYL(1-2)]BETA DEXTRO GLUCOPYRANOSIDE; PENNOGENIN 3 O BETA DEXTRO GLUCOPYRANOSYL(1-2)[O ALPHA LEVO RHAMNOPYRANOSYL(1-3)]BETA DEXTRO GLUCOPYRANOSIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PLANT EXTRACT; PROTEIN KINASE; PROTEIN KINASE B; RHIZOMA PARIDIS EXTRACT; SAPONIN DERIVATIVE; UNCLASSIFIED DRUG; HERBACEOUS AGENT; MITOGEN ACTIVATED PROTEIN KINASE; SAPONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL STRAIN HEPG2; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG ISOLATION; DRUG MECHANISM; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IN VIVO STUDY; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SPECTROSCOPY; TUMOR XENOGRAFT; ANIMAL; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECTS; DRUG SCREENING; ENZYMOLOGY; HEPG2 CELL LINE; LIVER NEOPLASMS; METABOLISM; NUDE MOUSE; PATHOLOGY;

ANIMALS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CASPASES; CELL PROLIFERATION; DRUGS, CHINESE HERBAL; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MICE; MICE, NUDE; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SAPONINS; SIGNAL TRANSDUCTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84896726398     PISSN: 0039128X     EISSN: 18785867     Source Type: Journal    
DOI: 10.1016/j.steroids.2014.01.014     Document Type: Article

References (31)

1. S.F. Altekruse, K.A. McGlynn, and M.E. Reichman Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005 J Clin Oncol 27 2009 1485 1491
2. M. Bai, N.R. Reynolds, and R. McCorkle The promise of clinical interventions for hepatocellular carcinoma from the west to mainland China Palliat Support Care 11 2013 1 20
3. J.W. Li, and J.C. Vederas Drug discovery and natural products: end of an era or an endless frontier? Science 325 2009 161 165
4. J.W. Ho, Y.K. Leung, and C.P. Chan Herbal medicine in the treatment of cancer Curr Med Chem Anticancer Agents 2 2002 209 214 (Pubitemid 34649873)
5. J. Sun, B.R. Liu, W.J. Hu, L.X. Yu, and X.P. Qian In vitro anticancer activity of aqueous extracts and ethanol extracts of fifteen traditional Chinese medicines on human digestive tumor cell lines Phytother Res 21 2007 1102 1104 (Pubitemid 350190311)
6. National Pharmacopoeia Committee Chonglou Pharmacopoeia of People's Republic of China. Part 1 2010 Chemical Industry Press Beijing 243 244
7. Y.X. Wang, and H.F. Li Study on the antitumor effects of Rhizoma paridis Chin Traditional Herbal Drugs 36 2005 628 630
8. J. Zhou Bioactive glycosides from Chinese medicines Mem Inst Oswaldo Cruz 86 1991 231 234
9. X.X. Huang, W.Y. Gao, S.L. Man, Y. Gao, L.Q. Huang, and C.X. Liu Isolation and identification of compounds present in rhizomes of Paris axialis H. and study of their cytotoxic effects Lat Am J Pharm 30 2011 540 545
10. H. Li The Genus Paris (Liliaceae) 1998 Science Press Beijing
11. J.Y. Cheung, R.C. Ong, Y.K. Suen, V. Ooi, H.N. Wong, and T.C. Mak et al. Polyphyllin D is a potent apoptosis inducer in drug-resistant HepG2 cells Cancer Lett 217 2005 203 211 (Pubitemid 40023119)
12. M.S. Lee, J.C. Yuet-Wa, S.K. Kong, B. Yu, V.O. Eng-Choon, and H.W. Nai-Ching et al. Effects of polyphyllin D, a steroidal saponin in Paris polyphylla, in growth inhibition of human breast cancer cells and in xenograft Cancer Biol Ther 4 2005 1248 1254
13. X. Xiao, P. Bai, T.M. Bui Nguyen, J. Xiao, S. Liu, and G. Yang et al. The antitumoral effect of Paris Saponin I associated with the induction of apoptosis through the mitochondrial pathway Mol Cancer Ther 8 2009 1179 1188
14. S. Man, W. Gao, Y. Yan, Z. Liu, and C. Liu Inhibition of matrix metalloproteinases related to metastasis by diosgenyl and pennogenyl saponins J Ethnopharmacol 137 2011 1221 1227
15. Y. Wang, Y.J. Zhang, W.Y. Gao, and L.L. Yan Anti-tumor constituents from Paris polyphylla var. yunnanensis Zhongguo Zhong Yao Za Zhi 32 2007 1425 1428
16. C. Chen, and J. Zhou Studies on the saponin components of plants in Yunnan X. two new steroidal saponins of Paris axialis H, Li. (1) Acta Botanica Yunnanica 6 1984 111 117
17. W. Zhao, W. Gao, X. Huang, L. Huang, and P. Xiao Chemical constituents from rhizome of Paris fargesii Franch Nat Prod Res Dev 23 2011 1017 1020
18. C. Chen, Y. Zhang, and J. Zhou Studies on the saponin components of plants in Yunnan VI. Stesoid glycosides of Paris ployphylla SM. var. yunnanensis (Fr.) H-M. (2) Acta Botanica Yunnanica 5 1988 91 97
19. H. Huynh, T.T. Nguyen, K.H. Chow, P.H. Tan, and K.C. Soo et al. Overexpression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: its role in tumor progression and apoptosis BMC Gastroenterol 3 2003 19
20. N.K. Saxena, D. Sharma, X. Ding, S. Lin, and F. Marra et al. Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells Cancer Res 67 2007 2497 2507 (Pubitemid 46548934)
21. S.S. Wu, W.Y. Gao, H.Q. Duan, and W. Jia Advances in studies on chemical constituents and pharmacological activities of Rhizoma paridis Chin Traditional and Herbal Drugs 35 2004 344 347
22. A. Ashkenazi Targeting death and decoy receptors of the tumor-necrosis factor superfamily Nat Rev Cancer 2 2002 420 430 (Pubitemid 37328939)
23. V. Gogvadze, S. Orrenius, and B. Zhivotovsky Mitochondria in cancer cells: what is so special about them? Trends Cell Biol. 18 2008 165 173
24. N. Joza, S.A. Susin, E. Daugas, W.L. Stanford, S.K. Cho, and C.Y. Li et al. Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death Nature 410 2001 549 554 (Pubitemid 32267191)
25. C.A. Wiesenauer, M.T. Yip-Schneider, Y. Wang, and C.M. Schmidt Multiple anticancer effects of blocking MEK-ERK signaling in hepatocellular carcinoma J Am Coll Surg 198 2004 410 421 (Pubitemid 38283732)
26. Z.G. Xia, M. Dickens, J. Raingeaud, R.J. Davis, and M.E. Greenberg Opposing effects of Erk and Jnk-P38 map kinases on apoptosis Science 270 1995 1326 1331
27. K. Nakanishi, M. Sakamoto, S. Yamasaki, S. Todo, and S. Hirohashi Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma Cancer 103 2005 307 312 (Pubitemid 40129290)
28. Y. Chen, B.C. Wang, and Y. Xiao PI3K: a potential therapeutic target for cancer J Cell Physiol 227 2012 2818 2821
29. A. Suzuki, M. Hayashida, H. Kawano, K. Sugimoto, and T. Nakano et al. Hepatocyte growth factor promotes cell survival from fas-mediated cell death in hepatocellular carcinoma cells via Akt activation and Fas-death-inducing signaling complex suppression Hepatology 32 2000 796 802
30. E. Tokunaga, E. Oki, A. Egashira, N. Sadanaga, M. Morita, and Y. Kakeji et al. Deregulation of the Akt pathway in human cancer Curr Cancer Drug Targets 8 2008 27 36 (Pubitemid 351237907)
31. K.A. West, S.S. Castillo, and P.A. Dennis Activation of the PI3K/Akt pathway and chemotherapeutic resistance Drug Resist Updates 5 2002 234 248 (Pubitemid 36132805)